FDA

FDA Asks Doctors and Pharmacists To Limit Acetaminophen

By |January 29th, 2014|

In January of 2011 the Food and Drug Administration (FDA) had asked drug manufacturers to limit the amount of acetaminophen to no more than 325 mg in each tablet or capsule by January 14, 2014. While more than 50% of manufacturers complied with this request, there were many who did not. Because of this, on January 14, 2014, the FDA asked health care professionals to stop prescribing dosages of medication that exceed 325 milligrams (mg) of acetaminophen and to help prevent, in most situations, a patient from receiving more. […]

Read More

FDA Regulating Internet Metadata and Keywords

By |February 20th, 2013|

By: Jeffrey Lapin

On January 29, 2013, the Food and Drug Administration (FDA) sent a “Warning Letter” to a Florida herbal supplement manufacturer alleging problems in their manufacturing process as well as marketing, on their website, some of their supplements as a “drug,” in violation of the Federal Food, Drug and Cosmetic Act (FD&C Act.). The marketing violation, based, in part, on results from the website’s search tool, seemingly indicates that the FDA is looking at “keywords” and metadata in determining whether a product’s online marketing violates the Act. […]

Read More

Online Contact Form

NOTE: An asterisk (*) indicates REQUIRED information.

DISCLAIMER: The use of this form or the Internet for communication with Lapin Law Offices or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form. Please do not send any confidential information until such time as an attorney-client relationship has been established. Your personal information is necessary in order for Lapin Law Offices to do a conflict of interest check prior to responding.

Lapin Law Offices does not offer the following services regarding debt: financial planning; money management; debt consolidation; debt negotiation; credit counseling; or bankruptcy representation.